oatawa/iStock via Getty Images
Hims & Hers Health (NYSE:HIMS) said that it has introduced affordable treatment options for those going through perimenopause and menopause.
The menopause care expands on its services into hormone-replacement therapies.
The stock of the company is up 2%.
Hims & Hers added